These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 2286182)

  • 1. Cigarette smoking and oral contraceptive use influence women's lipid, lipoprotein, and cardiovascular responses during stress.
    Davis MC; Matthews KA
    Health Psychol; 1990; 9(6):717-36. PubMed ID: 2286182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral contraceptive use and hemodynamic, lipid, and fibrinogen responses to smoking and stress in women.
    Davis MC
    Health Psychol; 1999 Mar; 18(2):122-30. PubMed ID: 10194047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study of the interactive effects of oral contraceptive use and dietary fat intake on blood pressure, cardiovascular reactivity and glucose tolerance in normotensive women.
    Straznicky NE; Barrington VE; Branley P; Louis WJ
    J Hypertens; 1998 Mar; 16(3):357-68. PubMed ID: 9557929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations of oral contraceptive use with serum lipids and lipoproteins in young women: the Bogalusa Heart Study.
    Greenlund KJ; Webber LS; Srinivasan S; Wattigney W; Johnson C; Berenson GS
    Ann Epidemiol; 1997 Nov; 7(8):561-7. PubMed ID: 9408552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fasting plasma lipids, lipoproteins and apolipoproteins in Nigerian women using combined oral and progestin-only injectable contraceptives.
    Oyelola OO
    Contraception; 1993 May; 47(5):445-54. PubMed ID: 8513671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
    Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular and mood responses to quantified doses of cigarette smoke in oral contraceptive users and nonusers.
    Masson CL; Gilbert DG
    J Behav Med; 1999 Dec; 22(6):589-604. PubMed ID: 10650538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haemostasis profile in smoking and nonsmoking women taking low-dose oral contraceptives.
    Fruzzetti F; Ricci C; Fioretti P
    Contraception; 1994 Jun; 49(6):579-92. PubMed ID: 8070263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipids and cardiovascular disease: do the findings and therapy apply equally to men and women?
    LaRosa JC
    Womens Health Issues; 1992; 2(2):102-11; discussion 111-3. PubMed ID: 1617306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The interaction of alcohol consumption and oral contraceptive use on lipids and lipoproteins.
    Kruszon-Moran D; Burkman RT; Kimball AW; Bachorik PS; Gold EB
    Contraception; 1988 Jan; 37(1):39-51. PubMed ID: 3365983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of low-dose oral contraceptives on cardiorespiratory function, coagulation, and lipids in exercising young women: a preliminary report.
    Notelovitz M; Zauner C; McKenzie L; Suggs Y; Fields C; Kitchens C
    Am J Obstet Gynecol; 1987 Mar; 156(3):591-8. PubMed ID: 3826206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse influences of alcohol, tobacco, and oral contraceptive use on cardiovascular risk factors during transition to adulthood.
    Croft JB; Freedman DS; Cresanta JL; Srinivasan SR; Burke GL; Hunter SM; Webber LS; Smoak CG; Berenson GS
    Am J Epidemiol; 1987 Aug; 126(2):202-13. PubMed ID: 3605049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationships between blood pressure, oral contraceptive use and metabolic risk markers for cardiovascular disease.
    Godsland IF; Crook D; Devenport M; Wynn V
    Contraception; 1995 Sep; 52(3):143-9. PubMed ID: 7587185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The interaction of cigarette smoking, oral contraceptive use, and cardiovascular risk factor variables in children: the Bogalusa Heart Study.
    Webber LS; Hunter SM; Baugh JG; Srinivasan SR; Sklov MC; Berenson GS
    Am J Public Health; 1982 Mar; 72(3):266-74. PubMed ID: 7058967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative metabolic effects of three types of combined oral contraceptive pills in Chinese women.
    Prasad RN; Liew D; Ratnam SS
    Contraception; 1989 Jan; 39(1):21-35. PubMed ID: 2521321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of low dose oral contraceptives on very low density and low density lipoprotein metabolism.
    Walsh BW; Sacks FM
    J Clin Invest; 1993 May; 91(5):2126-32. PubMed ID: 8486779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The interactions of body weight, age, cigarette smoking and hormone usage with blood pressure and plasma lipids in an Australian community.
    Simons LA; Simons J; Jones AS
    Aust N Z J Med; 1984 Jun; 14(3):215-21. PubMed ID: 6594111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of two oral contraceptives containing ethinyl estradiol and gestodene or norgestimate on different lipid and lipoprotein parameters.
    Wiegratz I; Jung-Hoffmann C; Gross W; Kuhl H
    Contraception; 1998 Aug; 58(2):83-91. PubMed ID: 9773262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prevalence of hyperlipidemia in women and its association with use of oral contraceptives, sex hormone replacement therapy and nonlipid coronary artery disease risk factors. Canadian Heart Health Surveys Research Group.
    Connelly PW; Stachenko S; MacLean DR; Petrasovits A; Little JA
    Can J Cardiol; 1999 Apr; 15(4):419-27. PubMed ID: 10322251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular disease: pathogenesis, epidemiology, and risk among users of oral contraceptives who smoke.
    Castelli WP
    Am J Obstet Gynecol; 1999 Jun; 180(6 Pt 2):S349-56. PubMed ID: 10368520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.